NO20004860D0 - Makrolid LHRH antagonister - Google Patents

Makrolid LHRH antagonister

Info

Publication number
NO20004860D0
NO20004860D0 NO20004860A NO20004860A NO20004860D0 NO 20004860 D0 NO20004860 D0 NO 20004860D0 NO 20004860 A NO20004860 A NO 20004860A NO 20004860 A NO20004860 A NO 20004860A NO 20004860 D0 NO20004860 D0 NO 20004860D0
Authority
NO
Norway
Prior art keywords
lhrh antagonists
macrolide
compounds
disclosed
antagonists
Prior art date
Application number
NO20004860A
Other languages
English (en)
Other versions
NO20004860L (no
Inventor
Daryl R Sauer
Fortuna Haviv
John Randolph
Nicholas A Mort
Christopher Robin Dalton
Milan Bruncko
Michele A Kaminski
Bradley W Crawford
Lisa Marie Frey
Jonathan Greer
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of NO20004860D0 publication Critical patent/NO20004860D0/no
Publication of NO20004860L publication Critical patent/NO20004860L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Epidemiology (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO20004860A 1998-03-27 2000-09-27 Makrolid LHRH antagonister NO20004860L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/049,963 US5955440A (en) 1998-03-27 1998-03-27 Macrolide LHRH antagonists
PCT/US1999/004658 WO1999050275A2 (en) 1998-03-27 1999-03-11 Macrolide lhrh antagonists

Publications (2)

Publication Number Publication Date
NO20004860D0 true NO20004860D0 (no) 2000-09-27
NO20004860L NO20004860L (no) 2000-11-24

Family

ID=21962689

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20004860A NO20004860L (no) 1998-03-27 2000-09-27 Makrolid LHRH antagonister

Country Status (20)

Country Link
US (1) US5955440A (no)
EP (1) EP1066304B1 (no)
JP (1) JP2002509937A (no)
KR (1) KR20010034694A (no)
CN (1) CN1307584A (no)
AT (1) ATE289609T1 (no)
AU (1) AU3067499A (no)
BG (1) BG104844A (no)
BR (1) BR9909080A (no)
CA (1) CA2325521A1 (no)
DE (1) DE69923835T2 (no)
ES (1) ES2238828T3 (no)
HU (1) HUP0102011A3 (no)
IL (1) IL138219A0 (no)
NO (1) NO20004860L (no)
PL (1) PL348242A1 (no)
PT (1) PT1066304E (no)
SK (1) SK13972000A3 (no)
TR (1) TR200002767T2 (no)
WO (1) WO1999050275A2 (no)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6387885B1 (en) * 1998-08-26 2002-05-14 Abbott Laboratories 3′,3′-N-bis-desmethyl-3′-N-cycloalkyl erythromycin derivatives as LHRH antagonists
KR20030011797A (ko) * 2000-03-28 2003-02-11 바이오케미 게젤샤프트 엠베하 맛이 차폐된 과립형 입자
EP1146051A3 (en) * 2000-04-10 2001-10-31 Pfizer Products Inc. Erythromycin A derivatives
AR043050A1 (es) * 2002-09-26 2005-07-13 Rib X Pharmaceuticals Inc Compuestos heterociclicos bifuncionales y metodos para preparar y usar los mismos
BRPI0408117A (pt) * 2003-03-05 2006-03-01 Rib X Pharmaceuticals Inc compostos heterocìclicos bifuncionais e métodos de produção e uso dos mesmos
WO2005042554A1 (en) * 2003-10-30 2005-05-12 Rib-X Pharmaceuticals, Inc. Bifunctional macrolide heterocyclic compounds and methods of making and using the same
JP2007512256A (ja) * 2003-11-18 2007-05-17 リブ−エックス ファーマシューティカルズ，インコーポレイテッド 二官能性マクロライド複素環化合物ならびにこれらを製造する方法およびこれらを使用する方法
EP2716647A3 (en) * 2004-02-27 2014-08-20 Rib-X Pharmaceuticals, Inc. Macrocyclic compounds and methods of making and using the same
EP2233493A1 (en) * 2004-12-21 2010-09-29 Pfizer Products Inc. Macrolides
ES2582794T3 (es) * 2009-08-13 2016-09-15 Basilea Pharmaceutica Ag Nuevos macrólidos y su uso

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6187625A (ja) * 1984-10-05 1986-05-06 Satoshi Omura 消化管収縮運動促進剤
EP0215355B1 (en) * 1985-08-31 1994-04-06 Kitasato Kenkyusho Erythromycin derivative and process for preparing the same
US4742049A (en) * 1986-06-04 1988-05-03 Abbott Laboratories Semisynthetic erythromycin antibiotics
US4920102A (en) * 1988-04-18 1990-04-24 Eli Lilly And Company Method for treating gastrointestinal disorders
IL99995A (en) * 1990-11-21 1997-11-20 Roussel Uclaf Erythromycin derivatives, their preparation and pharmaceutical compositions containing them
DE69127457T2 (de) * 1990-11-28 1998-01-22 Taisho Pharmaceutical Co., Ltd., Tokio/Tokyo 6-0-methylerythromycin a-derivat
FR2727969B1 (fr) * 1994-12-09 1997-01-17 Roussel Uclaf Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
CZ183998A3 (cs) * 1995-12-14 1998-10-14 Merck And Co., Inc. Nepeptidové deriváty, antagonizující hormon, uvolňující gonadotropin
DK1007530T3 (da) * 1996-05-07 2006-04-03 Abbott Lab 6-O-substituerede erythromycinforbindelser samt fremgangsmåde til fremstilling heraf

Also Published As

Publication number Publication date
PL348242A1 (en) 2002-05-20
CA2325521A1 (en) 1999-10-07
DE69923835T2 (de) 2006-04-06
HUP0102011A3 (en) 2003-07-28
EP1066304B1 (en) 2005-02-23
ES2238828T3 (es) 2005-09-01
EP1066304A1 (en) 2001-01-10
SK13972000A3 (sk) 2001-07-10
TR200002767T2 (tr) 2001-05-21
BG104844A (en) 2001-07-31
PT1066304E (pt) 2005-06-30
HK1036284A1 (en) 2001-12-28
ATE289609T1 (de) 2005-03-15
WO1999050275A2 (en) 1999-10-07
NO20004860L (no) 2000-11-24
WO1999050275A3 (en) 2001-02-22
HUP0102011A2 (hu) 2001-11-28
KR20010034694A (ko) 2001-04-25
DE69923835D1 (de) 2005-03-31
IL138219A0 (en) 2001-10-31
JP2002509937A (ja) 2002-04-02
BR9909080A (pt) 2000-12-12
US5955440A (en) 1999-09-21
AU3067499A (en) 1999-10-18
CN1307584A (zh) 2001-08-08

Similar Documents

Publication Publication Date Title
YU22399A (sh) Čvrsti farmaceutski sastavi koji obuhvataju ciklosporin i anjonsko površinski-aktivno sredstvo
HUP0103341A3 (en) Azetidine derivatives, preparation and pharmaceutical compositions thereof
DZ2509A1 (fr) Analogues peptidiques de la lh-rh leur utilisationet les compositions pharmaceutiques les contenant.
FR2708606B1 (fr) Dérivés du N-phénylalkylindol-2-one, leur préparation, les compositions pharmaceutiques en contenant.
KR100547921B1 (ko) 설폰아미드-치환된크로만,이의제조방법및이를포함하는약제학적조성물
AP9801253A0 (en) 9-Oxime erythromycin derivatives.
ATE272628T1 (de) Substituierte gamma-phenyl-delta-lactone und deren analoge, und ihre verwendungen
CA2335551A1 (en) Thyroid hormone analogues and methods for their preparation
IL137332A (en) Benzothiadiazoles and derivatives, their preparation and pharmaceutical compositions comprising them
PL348419A1 (en) Sustained-release pharmaceutical preparation containing tilidine mesylate as active ingredient
ATE289609T1 (de) Makrolid-lhrh-antagonisten
HUP0200363A3 (en) Lhrh antagonist decapeptides, pharmaceutical compositions comprising thereof and processes for their preparation
IS2258B (is) Setin tríasóló-pýridasín afleiða, lyfjasamsetningar gerðar úr henni
NZ506622A (en) 3',3'-N-bis-substituted macrolide LHRH antagonists
DK1054672T3 (da) Morfinsulfatmikrogranula, fremgangsmåde til fremstilling deraf og farmaceutiske præparater
ATE261425T1 (de) Erythromycin-derivate mit antibiotischer wirkung
HUP0203847A3 (en) Substituted homopiperidinyl benzimidazole analogues as fundic relaxants, process for their preparation and pharmaceutical compositions containing them
EE03996B1 (et) Farmatseutilised kompositsioonid, nende valmistamismeetod ja kasutamine
HUP0101234A3 (en) Betha-carboline derivatives, process for their preparation and pharmaceutical compositions thereof
EP1059304A4 (en) NOVEL POLYSACCHARIDE DERIVATIVES, PROCESS FOR PRODUCING THE SAME, AND MEDICINAL COMPOSITIONS CONTAINING THESE NEW DERIVATIVES AS ACTIVE INGREDIENT
FR2766489B1 (fr) Derives de streptogramines, leur preparation et les compositions qui les contiennent
FR2783521B1 (fr) Derives de n-(arginyl) benzenesulfonamide, leur preparation et leur application en therapeutique
EE200100196A (et) a-tsüklodekstriinil põhinevad farmatseutilised kompositsioonid LH-RH analoogide peroraalseks manustamiseks
HUP0103212A3 (en) 2-oxo-2h-quinoline derivatives, pharmaceutical compositions containing them and processes for their preparation
IT1301967B1 (it) Derivato di eritromicina ad attivita' antibiotica

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application